We are live on ! Find out more
MVM

Medicxi Ventures Management Portfolio holdings

AUM $982M
1-Year Est. Return 210.17%
This Fund
S&P 500
This Quarter Est. Return
+85.41%
1 Year Est. Return
+210.17%
3 Year Est. Return
+787.54%
5 Year Est. Return
+404.19%
10 Year Est. Return
–
AUM
$744M
AUM Growth
+$317M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTA
1
DELISTED
Centessa Pharmaceuticals
CNTA
$484M 65.03%
19,963,157
– –
PHAT icon
2
Phathom Pharmaceuticals
PHAT
$708M
$87.9M 11.8%
7,464,572
– –
NAMS icon
3
NewAmsterdam Pharma
NAMS
$3.25B
$81.6M 10.96%
2,869,565
– –
RAPT
4
DELISTED
RAPT Therapeutics
RAPT
$72.1M 9.68%
2,794,000
– –
AURA icon
5
Aura Biosciences
AURA
$725M
$18.8M 2.52%
3,039,892
– –

Similar funds

BIP
Blueprint Investment Partners Greensboro, North Carolina $980M AUM 27.19% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
PCM
Politan Capital Management New York $985M AUM 3.12% 1-Year Est. Return
MFWP
Mosaic Family Wealth Partners St. Louis, Missouri $977M AUM 19.09% 1-Year Est. Return
FCM
Fortis Capital Management Bellevue, Washington $977M AUM 17.17% 1-Year Est. Return
FFS
Forge Financial Services Edmond, Oklahoma $987M AUM 14.12% 1-Year Est. Return
PCM
Polymer Capital Management New York $988M AUM 56.33% 1-Year Est. Return
RCG
Rock Creek Group Washington, District of Columbia $988M AUM 8.89% 1-Year Est. Return

Medicxi Ventures Management's Q3 2025 Portfolio in Review

As of Q3 2025, Medicxi Ventures Management held 5 positions worth $744M, up 74% from $427M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2025: portfolio turnover was 0%. Medicxi Ventures Management opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Medicxi Ventures Management's ten largest holdings make up 100% of its $744M portfolio in Q3 2025.
  • Medicxi Ventures Management opened 0 new positions and closed 0 in Q3 2025.
  • Medicxi Ventures Management's portfolio value rose 74% quarter-over-quarter to $744M.

Based on Medicxi Ventures Management's 13F filing for Q3 2025, filed 17 Oct 2025.